help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeGroot, L. J.
Right arrow Articles by Straus, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeGroot, L. J.
Right arrow Articles by Straus, F. H.

Journal of Clinical Endocrinology & Metabolism, Vol 71, 414-424, Copyright © 1990 by Endocrine Society

ARTICLES

Natural history, treatment, and course of papillary thyroid carcinoma

LJ DeGroot, EL Kaplan, M McCormick and FH Straus
Department of Medicine, University of Chicago, Illinois 60637.

We have analyzed the course of papillary thyroid carcinoma in 269 patients managed at the University of Chicago, with an average follow- up period of 12 yr from the time of diagnosis. Patients were categorized by clinical class; I, with intrathyroidal disease; II, with cervical nodal metastases; III, with extrathyroidal invasion; and IV, with distant metastases. Half of the patients had a history of thyroid enlargement known, on the average, for over 3 yr. In 15% of patients given thyroid hormone, the mass decreased in size. The peak incidence of cancer was when subjects were between 20-40 yr of age. Tumors averaged 2.4 cm in size; 21.6% had tumor capsule invasion, and 46% of patients had multifocal tumors. Sixty-six percent of the patients had near-total or total thyroidectomy. The overall incidence of postoperative hypoparathyroidism was 8.4%, but the incidence was zero in 83 near-total or total thyroidectomies carried out by 1 surgeon. Twenty-five percent of the patients had continuing or recurrent disease, and 8.2% died from cancer. Deaths occurred largely in patients with class III or IV disease. Cervical lymph nodes were associated with increased recurrences, but not increased deaths. Extrathyroidal invasion carried an increased risk of 5.8-fold for death, and distant metastases increased this risk 47-fold. Age over 45 yr at diagnosis increased the risk of death 32-fold. Tumor size over 3 cm increased the risk of death 5.8-fold. Surgical treatment combining lobectomy plus at least contralateral subtotal thyroidectomy was associated, by Cox proportional hazard analysis, with decreased risk of death in patients with tumors larger than 1 cm and decreased risk of recurrence among all patients, including patients in classes I and II, compared to patients who underwent unilateral thyroid surgery or bilateral subtotal resections. By chi 2 analysis, 131I ablation of residual thyroid tissue after operation was associated with decreased risk of recurrence in tumors larger than 1 cm and decreased risk of death in patients in classes I and II with tumors more than 1 cm in size. The data strongly support the use of more extensive initial surgery in class I and II patients with tumors more than 1 cm in size as well as postoperative radioactive 131I ablation of thyroid remnant tissue.


This article has been cited by other articles:


Home page
 RadiologyHome page
W.-J. Moon, S. L. Jung, J. H. Lee, D. G. Na, J.-H. Baek, Y. H. Lee, J. Kim, H. S. Kim, J. S. Byun, D. H. Lee, et al.
Benign and Malignant Thyroid Nodules: US Differentiation--Multicenter Retrospective Study
Radiology, June 1, 2008; 247(3): 762 - 770.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A.-L. Borel, R. Boizel, P. Faure, G. Barbe, J. Boutonnat, N. Sturm, D. Seigneurin, I. Bricault, J.-P. Caravel, P. Chaffanjon, et al.
Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer
Eur. J. Endocrinol., May 1, 2008; 158(5): 691 - 698.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. Toniato, I. Boschin, D. Casara, R. Mazzarotto, D. Rubello, and M. Pelizzo
Papillary Thyroid Carcinoma: Factors Influencing Recurrence and Survival
Ann. Surg. Oncol., May 1, 2008; 15(5): 1518 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Bardet, E. Malville, J.-P. Rame, E. Babin, G. Samama, D. De Raucourt, J.-J. Michels, Y. Reznik, and M. Henry-Amar
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma.
Eur. J. Endocrinol., April 1, 2008; 158(4): 551 - 560.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
R Gupta, S Viswanathan, A D'Cruz, and S V Kane
Metastatic papillary carcinoma of thyroid masquerading as a renal tumour
J. Clin. Pathol., January 1, 2008; 61(1): 143 - 143.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Xing
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
Endocr. Rev., December 1, 2007; 28(7): 742 - 762.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Sakano, M. Takahashi, M. Mutoh, N. Niho, M. Komiya, H. Sato, T. Tanaka, T. Sugimura, and K. Wakabayashi
Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus
Carcinogenesis, October 1, 2007; 28(10): 2193 - 2198.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
P. Z. Pace-Asciak, R. J. Payne, S. J. Eski, P. Walfish, M. Damani, and J. L. Freeman
Cost Savings of Patients With a MACIS Score Lower Than 6 When Radioactive Iodine Is Not Given
Arch Otolaryngol Head Neck Surg, September 1, 2007; 133(9): 870 - 873.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
A. Hu, J. Clark, R. J. Payne, S. Eski, P. G. Walfish, and J. L. Freeman
Extrathyroidal Extension in Well-Differentiated Thyroid Cancer: Macroscopic vs Microscopic as a Predictor of Outcome
Arch Otolaryngol Head Neck Surg, July 1, 2007; 133(7): 644 - 649.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
S. A.R. Doi, N. J. Woodhouse, L. Thalib, and A. Onitilo
Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited
Clin. Med. Res., June 1, 2007; 5(2): 87 - 90.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. Lang, C.-Y. Lo, W.-F. Chan, K.-Y. Lam, and K.-Y. Wan
Restaging of Differentiated Thyroid Carcinoma by the Sixth Edition AJCC/UICC TNM Staging System: Stage Migration and Predictability
Ann. Surg. Oncol., May 1, 2007; 14(5): 1551 - 1559.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
B. H.-H. Lang, C.-Y. Lo, W.-F. Chan, K.-Y. Lam, and K.-Y. Wan
Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
Endocr. Relat. Cancer, March 1, 2007; 14(1): 29 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. H.-H. Lang, C.-Y. Lo, W.-F. Chan, K.-Y. Lam, and K.-Y. Wan
Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging
Ann. Surg. Oncol., February 1, 2007; 14(2): 730 - 738.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Wada, H. Nakayama, N. Suganuma, Y. Masudo, Y. Rino, M. Masuda, and T. Imada
Prognostic Value of the Sixth Edition AJCC/UICC TNM Classification for Differentiated Thyroid Carcinoma with Extrathyroid Extension
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 215 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
P. Siironen, A. Ristimaki, K. Narko, S. Nordling, J. Louhimo, S. Andersson, R. Haapiainen, and C. Haglund
VEGF-C and COX-2 expression in papillary thyroid cancer.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 465 - 473.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. Y. Greenblatt, T. Woltman, J. Harter, J. Starling, E. Mack, and H. Chen
Fine-Needle Aspiration Optimizes Surgical Management in Patients With Thyroid Cancer
Ann. Surg. Oncol., June 1, 2006; 13(6): 859 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. Are and A. R. Shaha
Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches
Ann. Surg. Oncol., April 1, 2006; 13(4): 453 - 464.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. F. A. Eustatia-Rutten, E. P. M. Corssmit, N. R. Biermasz, A. M. Pereira, J. A. Romijn, and J. W. Smit
Survival and Death Causes in Differentiated Thyroid Carcinoma
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 313 - 319.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
B Jarzab, D Handkiewicz-Junak, and J Wloch
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
Endocr. Relat. Cancer, December 1, 2005; 12(4): 773 - 803.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. C. Frates, C. B. Benson, J. W. Charboneau, E. S. Cibas, O. H. Clark, B. G. Coleman, J. J. Cronan, P. M. Doubilet, D. B. Evans, J. R. Goellner, et al.
Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement
Radiology, December 1, 2005; 237(3): 794 - 800.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. M. Vieira, S. C R. Santos, C. Espadinha, I. Correia, T. Vag, C. Casalou, B. M. Cavaco, A. L. Catarino, S. Dias, and V. Leite
Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop
Eur. J. Endocrinol., November 1, 2005; 153(5): 701 - 709.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Leboulleux, C. Rubino, E. Baudin, B. Caillou, D. M. Hartl, J.-M. Bidart, J.-P. Travagli, and M. Schlumberger
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5723 - 5729.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
J.-D. Lin, S.-T. Chen, T.-C. Chao, C. Hsueh, and H.-F. Weng
Diagnosis and Therapeutic Strategy for Papillary Thyroid Microcarcinoma
Arch Surg, October 1, 2005; 140(10): 940 - 945.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Ma, J. Xie, and A. Kuang
Is Empiric 131I Therapy Justified for Patients with Positive Thyroglobulin and Negative 131I Whole-Body Scanning Results?
J. Nucl. Med., July 1, 2005; 46(7): 1164 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. L. Motti, D. Califano, G. Baldassarre, A. Celetti, F. Merolla, F. Forzati, M. Napolitano, B. Tavernise, A. Fusco, and G. Viglietto
Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas
Carcinogenesis, June 1, 2005; 26(6): 1021 - 1034.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
F. A Verburg, B. de Keizer, C. J M Lips, P. M J Zelissen, and J. M H de Klerk
Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients
Eur. J. Endocrinol., January 1, 2005; 152(1): 33 - 37.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
P. I. Haigh, D. R. Urbach, and L. E. Rotstein
Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer
Ann. Surg. Oncol., January 1, 2005; 12(1): 81 - 89.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Rouxel, G. Hejblum, M.-O. Bernier, P.-Y. Boelle, F. Menegaux, G. Mansour, C. Hoang, A. Aurengo, and L. Leenhardt
Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5362 - 5368.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Furuya, H. Shimura, A. Miyazaki, K. Taki, K. Ohta, K. Haraguchi, T. Onaya, T. Endo, and T. Kobayashi
Adenovirus-Mediated Transfer of Thyroid Transcription Factor-1 Induces Radioiodide Organification and Retention in Thyroid Cancer Cells
Endocrinology, November 1, 2004; 145(11): 5397 - 5405.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Jukkola, R. Bloigu, T. Ebeling, P. Salmela, and G. Blanco
Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications
Endocr. Relat. Cancer, September 1, 2004; 11(3): 571 - 579.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. M. Sawka, K. Thephamongkhol, M. Brouwers, L. Thabane, G. Browman, and H. C. Gerstein
A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3668 - 3676.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Pellegriti, C. Scollo, G. Lumera, C. Regalbuto, R. Vigneri, and A. Belfiore
Clinical Behavior and Outcome of Papillary Thyroid Cancers Smaller than 1.5 cm in Diameter: Study of 299 Cases
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3713 - 3720.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
P. W. S. do Rosario, T. A. Fagundes, F. F. R. Maia, A. C. H. M. Franco, M. B. Figueiredo, and S. Purisch
Sonography in the Diagnosis of Cervical Recurrence in Patients With Differentiated Thyroid Carcinoma
J. Ultrasound Med., July 1, 2004; 23(7): 915 - 920.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Toubeau, C. Touzery, P. Arveux, G. Chaplain, G. Vaillant, A. Berriolo, J.-M. Riedinger, C. Boichot, A. Cochet, and F. Brunotte
Predictive Value for Disease Progression of Serum Thyroglobulin Levels Measured in the Postoperative Period and After 131I Ablation Therapy in Patients with Differentiated Thyroid Cancer
J. Nucl. Med., June 1, 2004; 45(6): 988 - 994.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Furuya, H. Shimura, H. Suzuki, K. Taki, K. Ohta, K. Haraguchi, T. Onaya, T. Endo, and T. Kobayashi
Histone Deacetylase Inhibitors Restore Radioiodide Uptake and Retention in Poorly Differentiated and Anaplastic Thyroid Cancer Cells by Expression of the Sodium/Iodide Symporter Thyroperoxidase and Thyroglobulin
Endocrinology, June 1, 2004; 145(6): 2865 - 2875.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. S. Bal, A. Kumar, and G. S. Pant
Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 Patients
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1666 - 1673.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
S. Kim, J. P. Wei, J. M. Braveman, and D. M. Brams
Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma
Arch Surg, April 1, 2004; 139(4): 390 - 394.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
K Kakudo, W Tang, Y Ito, Y Nakamura, H Yasuoka, S Morita, and A Miyauchi
Parathyroid invasion, nodal recurrence, and lung metastasis by papillary carcinoma of the thyroid
J. Clin. Pathol., March 1, 2004; 57(3): 245 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
T. G. Eccles, A. Patel, A. Verma, D. Nicholson, Y. Lukes, R. M. Tuttle, and G. L. Francis
Erythropoietin and the Erythropoietin Receptor Are Expressed by Papillary Thyroid Carcinoma fromChildren and Adolescents.: Expression of Erythropoietin Receptor Might Be a Favorable Prognostic Indicator
Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 411 - 422.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Barbaro, G. Boni, G. Meucci, U. Simi, P. Lapi, P. Orsini, C. Pasquini, F. Piazza, M. Caciagli, and G. Mariani
Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content in L-Thyroxine in the Outcome of Ablation
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4110 - 4115.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Modi, A. Patel, R. Terrell, R. M. Tuttle, and G. L. Francis
Papillary Thyroid Carcinomas from Young Adults and Children Contain a Mixture of Lymphocytes
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4418 - 4425.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. J. Robbins, S. M. Larson, N. Sinha, A. Shaha, C. Divgi, K. S. Pentlow, R. Ghossein, and R. M. Tuttle
A Retrospective Review of the Effectiveness of Recombinant Human TSH as a Preparation for Radioiodine Thyroid Remnant Ablation
J. Nucl. Med., November 1, 2002; 43(11): 1482 - 1488.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. F. Pingpank Jr, A. R. Sasson, A. L. Hanlon, C. D. Friedman, and J. A. Ridge
Tumor Above the Spinal Accessory Nerve in Papillary Thyroid Cancer That Involves Lateral Neck Nodes: A Common Occurrence
Arch Otolaryngol Head Neck Surg, November 1, 2002; 128(11): 1275 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Shah, K. Banks, A. Patel, S. Dogra, R. Terrell, P. A. Powers, C. Fenton, C. A. Dinauer, R. M. Tuttle, and G. L. Francis
Intense Expression of the B7-2 Antigen Presentation Coactivator Is an Unfavorable Prognostic Indicator for Differentiated Thyroid Carcinoma of Children and Adolescents
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4391 - 4397.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Pacini, M. Capezzone, R. Elisei, C. Ceccarelli, D. Taddei, and A. Pinchera
Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1499 - 1501.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. L. C. Khoo, N. J. P. Beasley, S. Ezzat, J. L. Freeman, and S. L. Asa
Overexpression of Cyclin D1 and Underexpression of p27 Predict Lymph Node Metastases in Papillary Thyroid Carcinoma
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1814 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. C. Roach, K. S. Heller, S. Dubner, and L. A. Sznyter
The Value of Frozen Section Examinations in Determining the Extent of Thyroid Surgery in Patients With Indeterminate Fine-Needle Aspiration Cytology
Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 263 - 267.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Kitamura, K. Shimizu, K. Ito, S. Tanaka, and M. Emi
Allelotyping of Follicular Thyroid Carcinoma: Frequent Allelic Losses in Chromosome Arms 7q, 11p, and 22q
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4268 - 4272.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Zafon, G. Obiols, J. CastellvI, N. Tallada, P. Galofre, E. Gemar, J. Mesa, and R. Simo
nm23-H1 Immunoreactivity as a Prognostic Factor in Differentiated Thyroid Carcinoma
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3975 - 3980.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
C. L. Fenton, A. Patel, H. B. Burch, R. M. Tuttle, and G. L. Francis
Nuclear Localization of Thyroid Transcription Factor-1 Correlates with Serum Thyrotropin Activity and May Be Increased in Differentiated Thyroid Carcinomas with Aggressive Clinical Course
Ann. Clin. Lab. Sci., July 1, 2001; 31(3): 245 - 252.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
E. Even-Sapir, Z. Keidar, J. Sachs, A. Engel, L. Bettman, D. Gaitini, L. Guralnik, N. Werbin, G. Iosilevsky, and O. Israel
The New Technology of Combined Transmission and Emission Tomography in Evaluation of Endocrine Neoplasms
J. Nucl. Med., July 1, 2001; 42(7): 998 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Shimura, H. Suzuki, A. Miyazaki, F. Furuya, K. Ohta, K. Haraguchi, T. Endo, and T. Onaya
Transcriptional Activation of the Thyroglobulin Promoter Directing Suicide Gene Expression by Thyroid Transcription Factor-1 in Thyroid Cancer Cells
Cancer Res., May 1, 2001; 61(9): 3640 - 3646.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. L. Mazzaferri and R. T. Kloos
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1447 - 1463.
[Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M.-O. Bernier, L. Leenhardt, C. Hoang, A. Aurengo, J.-Y. Mary, F. Menegaux, E. Enkaoua, G. Turpin, J. Chiras, G. Saillant, et al.
Survival and Therapeutic Modalities in Patients with Bone Metastases of Differentiated Thyroid Carcinomas
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1568 - 1573.
[Abstract] [Full Text]

Home page
 Arch Otolaryngol Head Neck SurgHome page
G. W. Randolph
Papillary Carcinoma of the Thyroid: Extent of Thyroidectomy
Arch Otolaryngol Head Neck Surg, April 1, 2001; 127(4): 462 - 463.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Gupta, A. Patel, A. Folstad, C. Fenton, C. A. Dinauer, R. M. Tuttle, R. Conran, and G. L. Francis
Infiltration of Differentiated Thyroid Carcinoma by Proliferating Lymphocytes Is Associated with Improved Disease-Free Survival for Children and Young Adults
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1346 - 1354.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. A. R. Doi
Usefulness of the Diagnostic Total Body Scan in Differentiated Thyroid Cancer
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 949 - 949.
[Full Text]

Home page
 Arch SurgHome page
A. Ohshima, H. Yamashita, S. Noguchi, S. Uchino, S. Watanabe, M. Toda, E. Koike, K. Takatu, and H. Yamashita
Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid
Arch Surg, October 1, 2000; 135(10): 1194 - 1198.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Kitamura, K. Shimizu, S. Tanaka, K. Ito, and M. Emi
Association of Allelic Loss on 1q, 4p, 7q, 9p, 9q, and 16q with Postoperative Death in Papillary Thyroid Carcinoma
Clin. Cancer Res., May 1, 2000; 6(5): 1819 - 1825.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. L. Fenton, Y. Lukes, D. Nicholson, C. A. Dinauer, G. L. Francis, and R. M. Tuttle
The ret/PTC Mutations Are Common in Sporadic Papillary Thyroid Carcinoma of Children and Young Adults
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1170 - 1175.
[Abstract] [Full Text]